Sandbox/WCT 1: Difference between revisions
Amr Marawan (talk | contribs) No edit summary |
Amr Marawan (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
==FIRE: Focused Initial Rapid Evaluation== | |||
A Focused Initial Rapid Evaluation (FIRE) should be performed to identify patients in need of immediate intervention.<ref name="pmid14563598">{{cite journal| author=Blomström-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ et al.| title=ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society. | journal=J Am Coll Cardiol | year= 2003 | volume= 42 | issue= 8 | pages= 1493-531 | pmid=14563598 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14563598 }} </ref><ref name="circ.ahajournals.org">{{Cite web | last = | first = | title = Part 7.3: Management of Symptomatic Bradycardia and Tachycardia | url = http://circ.ahajournals.org/content/112/24_suppl/IV-67.full | publisher = | date = | accessdate = 2 March 2014 }}</ref> | |||
<span style="font-size:85%">Boxes in salmon color signify that an urgent management is needed.</span> | |||
{{Family tree/start}} | |||
{{familytree | | | | | | | | | | | | | A01 | | |A01=<div style="float: left; text-align: left; width: 15em; padding:1em;">'''Identify cardinal findings that increase the pretest probability of wide complex tachycardia''' <br>❑ [[Palpitations]] <br> ❑ [[QRS complex]] > 120 ms <br>❑ [[Heart rate]] > 150 beats/min </div> <br> }} | |||
{{familytree | | | | | | | | | | | | | |!| | | }} | |||
{{familytree | | | | | | | | | | | | | B01 | | |B01=<div style="float: left; text-align: left; width: 13em; padding:1em;">'''Does the patient have any of the following findings that require urgent cardioversion?''' <br> | |||
❑ Hemodynamic instability | |||
:❑ [[Hypotension]] | |||
:❑ [[Cold extremities]] | |||
:❑ [[Cyanosis|Peripheral cyanosis]] | |||
:❑ [[Mottling]] | |||
:❑ [[Altered mental status]] | |||
❑ [[Chest discomfort]] suggestive of [[ischemia]] <br> | |||
❑ [[Heart failure|Decompensated heart failure]]</div>}} | |||
{{familytree | | | | | | | | | |,|-|-|-|^|-|-|-|.| | | | | | | | | | | }} | |||
{{familytree | | | | | | | | | B01 | | | | | | B02 | | | | | | | | | | |B01=<div style="float: left; text-align: central; background: #FA8072; width: 15em; padding:1em;"> {{fontcolor|#F8F8FF| '''Yes'''}} </div>|B02='''No'''}} | |||
{{familytree | | | | | | | | | |!| | | | | | | |!| | | | | | | | |}} | |||
{{familytree | | | | | | | | | |!| | | | | | | C02 | | | | |C02=<div style="float: left; text-align: left; width: 13em; padding:1em;"> ❑ '''[[Wide complex tachycardia resident survival guide#Complete Diagnostic Approach|Continue with the complete diagnostic approach below]]''' </div>}} | |||
{{familytree |boxstyle=background: #FA8072; color: #F8F8FF; | | | | | | | | | C03 | | | | | | | | | | | | | | | |C03=<div style="float: left; text-align: left; background: #FA8072; width: 13em; padding:1em;"> {{fontcolor|#F8F8FF| '''Proceed with immediate cardioversion''' <br> Perform the following without delaying cardioversion'''<br> ❑ Maintain patent airway; assist breathing as necessary<br> ❑ Adminster [[oxygen]] (if the patient is hypoxemic)<br> ❑ Cardiac monitor to identify rhythm; monitor [[blood pressure]] and oximetry <br> ❑ Give IV sedation if the patient is conscious<br> ❑ Don't delay cardioversion to sedate the patient <br> ❑ Consider expert consultation }} </div>}} | |||
{{familytree | | |,|-|-|-|v|-|-|-|+|-|-|-|v|-|-|-|.| | | | | | | |}} | |||
{{familytree |boxstyle=background: #FA8072; color: #F8F8FF; | A01 | | A02 | | A03 | | A04 | | A05 | | | | | | |A01=<div style=" width: 13em; padding:1em;"> <div style="background: #FA8072"> {{fontcolor|#F8F8FF| '''[[VT]]/[[VF]] presenting as [[cardiac arrest]]'''}} </div> </div>|A02=<div style=" width: 13em; padding:1em;"> <div style="background: #FA8072"> {{fontcolor|#F8F8FF| If the patient presents with polymorphic [[VT]] and is unstable}}</div> </div>|A03=<div style=" width: 13em; padding:1em;"> <div style="background: #FA8072"> {{fontcolor|#F8F8FF| '''Atrial fibrillation with aberrancy'''}}</div> </div>|A04=|A05=}} | |||
{{familytree | | |!| | | |!| | | |!| | | |!| | | |!| | | | | | | |}} | |||
{{familytree |boxstyle=background: #FA8072; color: #F8F8FF; | B01 | | B02 | | B03 | | B04 | | B05 | | | | | | |B01=<div style=" width: 13em; padding:1em;"> <div style="background: #FA8072"> {{fontcolor|#F8F8FF| '''[[Cardiac arrest resident survival guide|<span style="color:white;">Click here for cardiac arrest resident survival guide</span>]]''' }} </div> </div>|B02=<div style=" width: 13em; padding:1em;"> <div style="background: #FA8072"> {{fontcolor|#F8F8FF| '''Unsynchronized cardioversion'''<br> | |||
❑ Immediately deliver high-energy unsynchronized shocks <br> | |||
:❑ Provide an initial shock of 200 Joules<br> | |||
:❑ Increase the dose if no response to the first shock (eg, 300 J, 360 J, 360 J) }}</div> </div>|B03=|B04=|B05=}} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | |||
{{Family tree/end}} | |||
{{familytree |boxstyle=background: #FA8072; color: #F8F8FF; | | | | A01 | | | A02 | | | A03 | | | | | | | | | | |A01=<div style=" width: 13em; padding:1em;"> <div style="background: #FA8072"> {{fontcolor|#F8F8FF| '''[[VT]]/[[VF]] presenting as [[cardiac arrest]]'''<br> '''[[Cardiac arrest resident survival guide|<span style="color:white;">Click here for cardiac arrest resident survival guide</span>]]''' }} </div> </div> |A02=<div style=" width: 13em; text-align: left; padding:1em;"> <div style="background: #FA8072"> {{fontcolor|#F8F8FF| '''Unsynchronized cardioversion'''<br> ❑ If a patient has polymorphic VT and is unstable, treat the rhythm as VF and deliver high-energy unsynchronized shocks <br> | |||
:❑ Provide an initial shock of 200 Joules<br> | |||
:❑ Increase the dose if no response to the first shock (eg, 300 J, 360 J, 360 J) }} </div> </div>|A03=<div style=" width: 13em; padding:1em;"> <div style="background: #FA8072"> {{fontcolor|#F8F8FF| '''Synchronized cardioversion''' }} </div> </div>}} | |||
{{familytree | | | | | | | | | | | |,|-|-|+|-|-|.| | | | | | | | }} | |||
{{familytree |boxstyle=background: #FA8072; color: #F8F8FF;| | | | | | | | | | D01 | | D02 | | D03 | | | | | | |D01=<div style="float: left; text-align: left; background: #FA8072; width: 13em; padding:1em;"> {{fontcolor|#F8F8FF| '''Atrial fibrillation with aberrancy''' | |||
:❑ Provide an initial dose of biphasic cardioversion of 120-200 Joules ([[ACC AHA guidelines classification scheme|<span style="color:white;">Class IIa, level of evidence A</span>]]) | |||
:❑ If the initial shock fails, increase the dose in a stepwise fashion }} </div>|D02=<div style="float: left; text-align: left; background: #FA8072; width: 13em; padding:1em;"> {{fontcolor|#F8F8FF| '''Arial flutter and other SVTs with aberrancy''' | |||
:❑ Provide an initial dose of biphasic cardioversion of 50-100 Joules ([[ACC AHA guidelines classification scheme|<span style="color:white;">Class IIa, level of evidence B</span>]]) | |||
:❑ If the initial shock fails, increase the dose in a stepwise fashion | |||
:❑ If monophasic wave form is used, begin at 200 Joules and increase in stepwise fashion if not successful }} </div>|D03=<div style="float: left; text-align: left; background: #FA8072; width: 13em; padding:1em;"> {{fontcolor|#F8F8FF| '''Monomorphic VT (regular form and rate)''' | |||
:❑ Provide an initial dose of biphasic cardioversion of 100 Joules ([[ACC AHA guidelines classification scheme|<span style="color:white;">Class IIb, level of evidence C</span>]]) | |||
:❑ If the initial shock fails, increase the dose in a stepwise fashion }} </div> }} | |||
{{familytree | | | | | | | | | | |`|-|-|-|+|-|-|-|'| | | | | | | | | | | | }} | |||
{{familytree | | | | | | | | | | | | | | | D01 | | |D01= <div style="float: left; text-align: left; width: 13em; padding:1em;">❑ '''[[Wide complex tachycardia resident survival guide#Complete Diagnostic Approach|After the stabilization of the patient, continue with the complete diagnostic approach below]]''' </div>}} | |||
{{Family tree/end}} | |||
{{Family tree/start}} | {{Family tree/start}} | ||
{{familytree | | | | | | | | | A01 | | | | | | | | | | | | | | | |A01= [[Wide complex tachycardia]] <br> QRS ≥ 120ms}} | {{familytree | | | | | | | | | A01 | | | | | | | | | | | | | | | |A01= [[Wide complex tachycardia]] <br> QRS ≥ 120ms}} |
Revision as of 15:19, 16 April 2014
FIRE: Focused Initial Rapid Evaluation
A Focused Initial Rapid Evaluation (FIRE) should be performed to identify patients in need of immediate intervention.[1][2]
Boxes in salmon color signify that an urgent management is needed.
Identify cardinal findings that increase the pretest probability of wide complex tachycardia ❑ Palpitations ❑ QRS complex > 120 ms ❑ Heart rate > 150 beats/min | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Does the patient have any of the following findings that require urgent cardioversion? ❑ Hemodynamic instability ❑ Chest discomfort suggestive of ischemia | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Proceed with immediate cardioversion Perform the following without delaying cardioversion ❑ Maintain patent airway; assist breathing as necessary ❑ Adminster oxygen (if the patient is hypoxemic) ❑ Cardiac monitor to identify rhythm; monitor blood pressure and oximetry ❑ Give IV sedation if the patient is conscious ❑ Don't delay cardioversion to sedate the patient ❑ Consider expert consultation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
VT/VF presenting as cardiac arrest | If the patient presents with polymorphic VT and is unstable | Atrial fibrillation with aberrancy | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Unsynchronized cardioversion ❑ Immediately deliver high-energy unsynchronized shocks
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
❑ If a patient has polymorphic VT and is unstable, treat the rhythm as VF and deliver high-energy unsynchronized shocks
- ❑ Provide an initial shock of 200 Joules
- ❑ Increase the dose if no response to the first shock (eg, 300 J, 360 J, 360 J)
- ❑ Provide an initial dose of biphasic cardioversion of 120-200 Joules (Class IIa, level of evidence A)
- ❑ If the initial shock fails, increase the dose in a stepwise fashion
Wide complex tachycardia QRS ≥ 120ms | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Begin initial management ❑ Assess and support CAB as needed ❑ Give oxygen | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Determine if the patient has any unstable sign or symptom ❑ Chest pain ❑ Congestive heart failure | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Determine the regularity of the rhythm | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Irregular rhythm | Regular rhythm | ||||||||||||||||||||||||||||||||||||||||||||||||||||
VT or uncertain rhythm ❑ Give amiodarone 150 mg IV over 10 min ❑ Repeat amiodarone as needed for a maximal dose of 2.2g/24h | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Recurrent polymorphic VT ❑ Consider expert consultation | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Identify cardinal findings that increase the pretest probability of wide complex tachycardia ❑ Palpitations ❑ QRS complex > 120 ms ❑ Heart rate > 150 beats/min | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Does the patient have any of the following findings that require urgent cardioversion? ❑ Hemodynamic instability ❑ Chest discomfort suggestive of ischemia | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
❑ Yes | ❑ No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Prepare the patient for immediate cardioversion and simultaneously do the following: ❑ Maintain patent airway; assist breathing as necessary ❑ Adminster oxygen (if the patient is hypoxemic) ❑ Cardiac monitor to identify rhythm; monitor blood pressure and oximetry ❑ Give IV sedation if the patient is conscious (don't delay cardioversion to sedate the patient) ❑ Consider expert consultation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
VT/VF in the form of cardiac arrest Click here for Cardiac arrest resident survival guide | Unsynchronized cardioversion ❑ If a patient has polymorphic VT and is unstable, treat the rhythm as VF and deliver high-energy unsynchronized shocks
| Synchronized cardioversion | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atrial fibrillation with aberrancy
| Arial flutter and other SVTs with aberrancy
| Monomorphic VT (regular form and rate)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abbreviations: ECG: electrocardiogram; VT: ventricular tachycardia; VF: ventricular fibrillation; ICD: implantable cardioverter-defibrillator; BPM: beat per minute
Characterize the symptoms: ❑ Palpitations
❑ Duration
| |||||||||||||||||||||||||||||||||||||||||||||||||
Identify possible triggers: | |||||||||||||||||||||||||||||||||||||||||||||||||
Examine the patient:
Neck
Cardiovascular examination
❑ Inspection
❑ Palpation
| |||||||||||||||||||||||||||||||||||||||||||||||||
Order labs and tests: ❑ Order and monitor the ECG Perform urgent cardioversion in unstable patients
❑ Invasive electrophysiological studies ❑ Plasma concentration of drugs (eg,digoxin, quinidine or procainamide | |||||||||||||||||||||||||||||||||||||||||||||||||
Wide QRS complex tachycardia (QRS duration greater than 120 ms) | |||||||||||||||||||||||||||||||||||||||||||||||||
Regular or irregular? | |||||||||||||||||||||||||||||||||||||||||||||||||
Regular | Irregular | ||||||||||||||||||||||||||||||||||||||||||||||||
Is QRS identical to that during SR? If yes, consider: - SVT and BBB - Antidromic AVRT | Atrial fibrillation Atrial flutter / AT with variable conduction and: a) BBB or b) Antegrade conduction via AP | ||||||||||||||||||||||||||||||||||||||||||||||||
Vagal maneuvers or adenosine | |||||||||||||||||||||||||||||||||||||||||||||||||
Previous myocardial infarction or structural heart disease? If yes, VT is likely. | |||||||||||||||||||||||||||||||||||||||||||||||||
1 to 1 AV relationship? | |||||||||||||||||||||||||||||||||||||||||||||||||
Yes or unknown | No | ||||||||||||||||||||||||||||||||||||||||||||||||
V rate faster than A rate | A rate faster than V rate | ||||||||||||||||||||||||||||||||||||||||||||||||
QRS morphology in precordial leads | VT | Atrial tachycardia Atrial flutter | |||||||||||||||||||||||||||||||||||||||||||||||
Typical RBBB or LBBB | Precordial leads: - Concordant - No R/S pattern - Onset of R to nadir longer than 100ms | RBBB pattern: - qR, Rs or Rr' in V1 - Frontal plane axis range from +90 degrees to -90 degrees | LBBB pattern: - R in V1 longer than 30 ms - R to nadir of S in V1 greater than 60 ms - qR or qS in V6 | ||||||||||||||||||||||||||||||||||||||||||||||
SVT | VT | VT | VT | ||||||||||||||||||||||||||||||||||||||||||||||
The above algorithm is adapted from the 2003 American College of Cardiology.[1]
- ↑ 1.0 1.1 Blomström-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ; et al. (2003). "ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society". J Am Coll Cardiol. 42 (8): 1493–531. PMID 14563598.
- ↑ "Part 7.3: Management of Symptomatic Bradycardia and Tachycardia". Retrieved 2 March 2014.